Sebela Pharmaceuticals
develops and markets prescription products for gastroenterology, dermatology and women’s health... Read moreSebela Pharmaceuticals
develops and markets prescription products for gastroenterology, dermatology and women’s health... Read more
News
Apr 25, 2025
Pharmabiz
Sebela Pharmaceuticals: Sebela Pharma announces positive results from phase 3 TRIUMpH programme of tegoprazan in GERD
Feb 25, 2025
PR Newswire
Press Release: Sebela Pharmaceuticals : FDA Approves MIUDELLA, the First Hormone-Free Copper Intrauterine System (IUS) in the U.S. in Over 40 Years, from Sebela Women's Health Inc.
Jan 24, 2025
PR Newswire
Press Release: Sebela Pharmaceuticals : Sebela Women's Health Announces Publication of Phase 3 Pivotal Study Results for the Investigational Copper 175 mm Intrauterine Device (IUD) in Contraception
Oct 30, 2023
StreetInsider
Press Release: Sebela Pharmaceuticals : Sebela Women's Health Announces Further Positive Data from the Pivotal Phase 3 Study of the Investigational Copper 175 mm Intra-Uterine Device (IUD)
Jun 22, 2023
StreetInsider
Press Release: Sebela Pharmaceuticals : FDA Approves Sebela Pharmaceuticals' SUFLAVE A New Colonoscopy Preparation that Tastes Similar to a Sports Drink
May 18, 2023
StreetInsider
Press Release: Sebela Pharmaceuticals : Sebela Women's Health Announces Positive Phase 3 Data for its Investigational, Next-Generation, Hormone-Free, Low-Dose Copper Intrauterine Device (IUD)
Mar 21, 2023
PR Newswire
Press Release: Sebela Pharmaceuticals : Sebela Women's Health Shares Findings from a Real-World Cost Comparison of Hormonal and Non-hormonal IUD Use Among Privately Insured Individuals in the U.S.
Feb 24, 2023
Marketscreener
Sebela Pharmaceuticals: Destiny Pharma plc Signs Collaboration and Co-Development Agreement with Sebela Pharmaceutical for NTCD-M3
Nov 15, 2022
PR Newswire
Press Release: Sebela Pharmaceuticals : Sebela Pharmaceuticals Announces New Division Named Sebela Women's Health
Oct 28, 2022
Life Care News
Sebela Pharmaceuticals: Sebela Pharmaceuticals Acquires Exclusive Licensing Rights to Develop and Commercialize Tegoprazan in the U.S. and Canada
Sebela Pharmaceuticals Competitors
1
2
3
4
5
6
7
8
9
10